The study of Japanese lung cancer patients' preferences using data from discrete choice experiment
Not Applicable
- Conditions
- ung Cancer
- Registration Number
- JPRN-UMIN000039087
- Lead Sponsor
- Chugai pharmaceutical Co., Ltd.
- Brief Summary
In Japanese lung cancer patients' preference, OS was the most important, followed by diarrhea, nausea, rash, bone marrow suppression, PFS, fatigue, interstitial lung disease, frequency of administration, and duration of administration. The preferences were influenced by demographic characteristics and disease background. Interestingly, the experience of cancer drug therapies and adverse events had a substantial impact on the hypothetical drug preferences.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
N/A
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method relative importance of attributes and levels of drug therapy
- Secondary Outcome Measures
Name Time Method relation between patients' demographics and relative importance of attributes and levels of drug therapy